Pars Today- The Islamic Republic of Iran, thanks to broad breakthroughs, stands among the three top countries in the field of marrow bone transplant.
The Islamic Republic of Iran, relying on native forces for the recent years, has been able to gain bedazzling progress in various medical fields including marrow bone transplant.
Marrow bone transplant has been carried out in persons suffering from diseases like Leukemia, myelodysplastic syndrome and other hematologic malignancies such as lymphoma, multiple myeloma and anemia aplastic. This transplant can also be used for a number of oncological cancers which do not accept chemotherapy such as testicular cancer, neuroblastoma, medullablastoma and also congenial disorders like thalassemia, sickle cell anemia, porphyria, and the acute immune deficiency.
The Iranian medical specialists have succeeded to make great progress in marrow bone transplant during the recent years. That’s why, Iran ranks among the three countries in the field so that an Iranian knowledge-based company has just produced the allogenic cellular treatment medicine “DestroCell” specifically used for marrow bone transplant patients.
DestroCell can notably reduce the Graft-versus-host disease (GVHD) side-effects. GVHD is among the diseases resulting from marrow bone transplant and has a lot of risks for the patient.
In view of this, Mostafa Qanei, Secretary of Biotechnology, Health and Medical Technologies Headquarters of Iran’s Presidential Scientific Deputy Department, said during the unveiling ceremony of DestroCell on October 29, 2024, “Iran is one of the pioneers in the region in the field of marrow bone transplant to the extent that the statistics of marrow bone transplant in Iran is very much ahead of the regional countries.”
Marrow bone transplant has a record of over three decades in Iran. As Ali Jafarian, Senior Advisor to the Iranian Minister of Health, Treatment and Medical Education, said on February 3, 2025, “17,000 marrow bone transplants have so far been done in Iran.”
RM/ME
